Rheumatology Clinical Registry

Rheumatoid Arthritis Clinical Trial

— RCR  

Official title:

American College of Rheumatology Clinical Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01813409
• Other study ID #: ACR-RCR
• Status: Recruiting
• Phase: N/A
• First received: March 15, 2013
• Last updated: August 29, 2014
• Start date: August 2009

Study information

• Verified date: August 2014
• Source: American College of Rheumatology
• Contact: Melissa Francisco
• Phone: 404-633-3777
• Email: mfrancisco[@]rheumatology.org
• Is FDA regulated: No
• Health authority: United States: American College of Rheumatology
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The ACR Rheumatology Clinical Registry (RCR) is a tool developed to assist members in practice improvement, local population management, and efficient, successful participation in national quality programs. RCR integrates evidence-based quality measures aimed at improving care and drug safety for patients with rheumatoid arthritis, osteoarthritis, osteoporosis, gout and juvenile idiopathic arthritis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 820
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Rheumatoid Arthritis

Exclusion Criteria:

Study Design

N/A

Related Conditions & MeSH terms

• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Locations

Country	Name	City	State
United States	Registry Site	Atlanta	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
American College of Rheumatology

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of the treatment of rheumatoid arthritis and other diseases		Up to a year	No
Secondary	Submission to federal reporting programs		Up to a year	No